GRIP Molecular Technologies, Inc’s Post

Transcript

Grips biosensor technology has the potential to establish a new healthcare norm. User administered diagnostic testing in the home telehealth interaction data, informed diagnosis and the prompt application of appropriate care with no need for a visit to the clinic. GRIP has scientific and clinical evidence that this vision of the future is not a dream. But instead a plausible reality. Together. We can make it happen. Rapid and accurate medical diagnosis is the gate through which personalized healthcare must pass. To realize its full potential. Today, we stand poised to unlock this gate. The key. Leverage of the power of GRIP Moleculars novel electronic biosensor technology. To transform a standard cell phone into a lab grade medical diagnostic instrument. Grips technology has the potential to fundamentally alter how numerous diseases and health conditions are detected, diagnosed, monitored and treated. By putting large diagnostic lab capabilities into the hands of consumers and their clinicians. It enables medical diagnostic testing to be performed by anyone, anywhere, at anytime. The GRIP biosensor technology can simultaneously detect multiple disease causing pathogens and health condition biomarkers in minutes. And display these results on the user's cell phone. These results are then ready for media transmission to a healthcare professional. Providing them unprecedented levels of timely and actionable diagnostic information. When sickness strikes, it's always concerning, never convenient, and the unknowns can be a significant source of stress. It's important to quickly and accurately diagnose what is causing the symptoms. So the appropriate treatment can be promptly applied to derive maximum benefit. Despite noteworthy advances. Today's medical diagnostic tests require significant tradeoffs between speed, accuracy. Multi biomarker detection convenience and cost. Most diagnostic tests that can be performed in the home do not provide the sensitivity required to detect the disease or health condition in the early stages. And none offered the broad multi biomarker diagnostic testing capability required to make well informed clinical diagnosis. The sophisticated diagnostic testing equipment that does offer these capabilities requires specialized equipment and often the need for skilled operators who work in a clinic or centralized lab environment. These factors make these tests expensive to utilize and inconvenient and time consuming to access. A better solution is required. GRIP is pursuing a different approach, unlike today's chemical based diagnostic tests. GRIP uses integrated circuit technology that is enhanced with the layer of graphene, to which biological caption molecules are applied using an inkjet printing process when these caption molecules on the graphene surface bind to a specific biomarker of interest. The electrical dynamics across the graphene change grip measures these electrical changes, digitizes the signal and sends it to the cell phone to display the results. This approach offers extraordinary diagnostic capabilities, great flexibility in what combination of biomarkers can be detected, and tremendous production scalability to meet demand as diagnostic needs evolve and new health threats arise. The GRIP system is very easy to use. A barcode on the outer packaging of the GRIP cartridge is first scanned using a standard cell phone to download a proprietary A to display the results at the time of use, a nasal secretion, saliva, urine or other appropriate sample is collected with the swab. And mixed with a buffer solution that is provided with a cartridge in a flexible container. The container is then capped and used to inject the solution into the cartridge. The biosensor inside the cartridge immediately interrogates the sample and sends the results to the cell phone for display and transmission. Numerous cartridge form factors and cell phone connectivity options can be envisioned, each tailored to the typical user and use case. It is important to highlight that the information that clinician will receive from the grid system will far surpass what they typically have available today both in terms of timeliness and data robustness. It will include multi biomarker detection results, pathogen variant and strain identification and indications of resistance to an appropriateness of various therapies. Artificial intelligence can be applied to analyze the detailed diagnostic information to GRIP test provides, which in combination with other health information about the patient. Can be used by the clinician to assess care options leveraging state-of-the-art medical guidelines. Identification and treatment of a wide variety of diseases and health conditions. Will benefit from the application of the GRIP diagnostic technology. Including urinary tract infection, sexually transmitted diseases, HIV, herpes, measles. Candida infections. Upper respiratory infections and the numerous infections that arise from mosquito transmission. Beyond the detection of disease causing pathogens. The grid technology can also be used to conveniently detect and monitor various health conditions. Including the measurement of hormones associated with fertility. And biomarkers associated with heart attack, kidney disease, and concussion. GRIP has completed extensive research of its electronic biosensor. These have demonstrated its extraordinary biomarker detection capabilities which are comparable to sophisticated lab based diagnostic testing equipment. This research evidence has been bolstered with clinical feasibility study results using nasal samples from infected COVID-19 patients. Here again. Extraordinary biomarker detection capability was observed. The future is bright for those who capitalize on the remarkable diagnostic capabilities found that the intersection of biology, electronics and digital health. Grip Molecular is in the middle of that intersection. Developing the next generation of medical diagnostic tests. That will provide the rapid, accurate and actionable medical diagnostic information we and our doctors need. When and where it matters most. At the point of need. Please go to our website www.gripmolecular.com to learn more about grip molecular and how you may be able to support our efforts. Thanks for watching.